Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dacarbazine”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01721746
What this trial is testing

Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Who this might be right for
Unresectable or Metastatic Melanoma
Bristol-Myers Squibb 405
Testing effectiveness (Phase 2)Study completedNCT00110994
What this trial is testing

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
CancerMelanoma
Bayer 101
Testing effectiveness (Phase 2)Study completedNCT00492297
What this trial is testing

A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 83
Testing effectiveness (Phase 2)Ended earlyNCT00354523
What this trial is testing

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Who this might be right for
Solid TumorThyroid Cancer
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT03023124
What this trial is testing

Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor

Who this might be right for
Solitary Fibrous Tumors
Italian Sarcoma Group 23
Early research (Phase 1)Study completedNCT00412581
What this trial is testing

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)UnknownNCT04843267
What this trial is testing

A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT

Who this might be right for
Hodgkin LymphomaChemotherapy Effect
Sun Yat-sen University 30
Large-scale testing (Phase 3)Ended earlyNCT00087776
What this trial is testing

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
American Regent, Inc. 393
Large-scale testing (Phase 3)Study completedNCT02545075
What this trial is testing

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

Who this might be right for
Melanoma
Bristol-Myers Squibb 182
Large-scale testing (Phase 3)Study completedNCT00016263
What this trial is testing

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Genta Incorporated
Testing effectiveness (Phase 2)UnknownNCT00553618
What this trial is testing

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 160
Testing effectiveness (Phase 2)Study completedNCT01152788
What this trial is testing

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Who this might be right for
Melanoma
NCIC Clinical Trials Group 64
Testing effectiveness (Phase 2)UnknownNCT00797472
What this trial is testing

Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease

Who this might be right for
Hodgkin's Disease
American Scitech International 120
Testing effectiveness (Phase 2)Looking for participantsNCT06984146
What this trial is testing

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
National Medical Research Radiological Centre of the Ministry of Health of Russia 54
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Testing effectiveness (Phase 2)Study completedNCT01164007
What this trial is testing

Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02979522
What this trial is testing

Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Takeda 59
Testing effectiveness (Phase 2)Study completedNCT00794235
What this trial is testing

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Who this might be right for
Melanoma Stage III or IVNo Prior Chemotherapy
University of Zurich 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05922904
What this trial is testing

PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00849875
What this trial is testing

Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
GlaxoSmithKline 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation